Long-lasting decrease in neuronal Ca2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent seizures

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 54-65

  Blair, Robert E ^a   Churn, Severn B ^a   Sombati, Sompong ^a   Lou, Jeffrey K ^a   DeLorenzo, Robert J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hippocampal; Magnesium; Neuronal culture; Phosphatase; Phosphorylation; Seizure

Indexed keywords

CYCLOSPORIN A; OKADAIC ACID; PHOSPHATASE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOREACTIVITY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECURRENT DISEASE; SEIZURE;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; HIPPOCAMPUS; MAGNESIUM CHLORIDE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; SEIZURES; SYNAPTIC TRANSMISSION;

EID: 0033398705     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02100-9     Document Type: Article

References (55)

1. A receptors in mouse cortical neurons. Pflug. Arch. 435:1998;382-387.
2. Bading H., Ginty D.D., Greenberg M.E. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science. 260:1993;181-186.
3. Banker G.A., Cowan W.M. Further observations on hippocampal neurons in dispersed cell culture. J. Comp. Neurol. 187:1979;469-493.
4. Bronstein J.M., Farber D.B., Wasterlain C.G. Regulation of type-II calmodulin kinase: functional implications. Brain Res. Brain Res. Rev. 18:1993;135-147.
5. Buhl E.H., Otis T.S., Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science. 271:1996;369-373.
6. 2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6852-6855.
7. Chiou J.Y., Westhead E.W. Okadaic acid, a protein phosphatase inhibitor, inhibits nerve growth factor-directed neurite outgrowth in PC12 cells. J. Neurochem. 59:1992;1963-1966.
8. Churn S.B., Anderson W.W., DeLorenzo R.J. Exposure of hippocampal slices to magnesium-free medium produces epileptiform activity and simultaneously decreases calcium and calmodulin-dependent protein kinase II activity. Epilepsy Res. 9:1991;211-217.
9. Churn S.B., DeLorenzo R.J. Modulation of GABAergic receptor binding by activation of calcium and calmodulin-dependent kinase II membrane phosphorylation. Brain Res. 809:1998;68-76.
10. Churn S.B., Limbrick D., Sombati S., DeLorenzo R.J. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase II activity in cultured hippocampal neurons. J. Neurosci. 15:1995;3200-3214.
11. Churn S.B., Sombati S., Taft W.C., DeLorenzo R.J. Excitotoxicity affects membrane potential and calmodulin kinase II activity in cultured rat cortical neurons. Stroke. 24:1993;271-277.
12. Churn S.B., Taft W.C., Billingsley M.S., Sankaran B., DeLorenzo R.J. Global forebrain ischemia induces a post-translational modification of multifunctional calcium- and calmodulin-dependent kinase II. J. Neurochem. 59:1992;1221-1232.
13. Churn S.B., Yaghmai A., Povlishock J., Rafiq A., DeLorenzo R.J. Global forebrain ischemia results in decreased immunoreactivity of calcium/calmodulin-dependent protein kinase II. J. Cereb. Blood Flow Metab. 12:1992;784-793.
14. Coulter D.A., Sombati S., DeLorenzo R.J. Electrophysiology of glutamate neurotoxicity in vitro: induction of a calcium-dependent extended neuronal depolarization. J. Neurophysiol. 68:1992;362-373.
15. DeLorenzo R.J. The calmodulin hypothesis of neurotransmission. Cell Calcium. 2:1981;365-385.
16. DeLorenzo R.J. Calcium-calmodulin protein phosphorylation in neuronal transmission: a molecular approach to neuronal excitability and anticonvulsant drug action. Adv. Neurol. 34:1983;325-338.
17. DeLorenzo R.J. A molecular approach to the calcium signal in brain: relationship to synaptic modulation and seizure discharge. Adv. Neurol. 44:1986;435-464.
18. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14482-14487. In Process Citation.
19. Didier M., Heaulme M., Soubrie P., Bockaert J., Pin J.P. Rapid, sensitive and simple method for quantification of both neurotoxic and neurotrophic effects of NMDA on cultured cerebellar granule cells. J. Neurosci. Res. 27:1990;25-35.
20. 2+/calmodulin-dependent protein kinase in rat brain. J. Neurosci. 5:1985;3270-3277.
21. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
22. Gibbs J.W., Sombati S., DeLorenzo R.J., Coulter D.A. Physiological and pharmacological alterations in postsynaptic GABA(A) receptor function in a hippocampal culture model of chronic spontaneous seizures. J. Neurophysiol. 77:1997;2139-2152.
23. Goldenring J.R., Vallano M.L., Lasher R.S., Ueda T., DeLorenzo R.J. Association of calmodulin-dependent kinase II and its substrate proteins with neuronal cytoskeleton. Prog. Brain Res. 69:1986;341-354.
24. Goldenring J.R., Wasterlain C.G., Oestreicher A.B., de G.P., Farber D.B., Glaser G., DeLorenzo R.J. Kindling induces a long-lasting change in the activity of a hippocampal membrane calmodulin-dependent protein kinase system. Brain Res. 377:1986;47-53.
25. 2+/calmodulin-dependent protein kinase and mutational analysis of its autoregulation. Neuron. 3:1989;59-70.
26. 2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61:1992;559-601.
27. Hashimoto Y., Soderling T.R. Calcium, calmodulin-dependent protein kinase II and calcium, phospholipid-dependent protein kinase activities in rat tissues assayed with a synthetic peptide. Arch. Biochem. Biophys. 252:1987;418-425.
28. W.A. Hauser, D.C. Hesdorffer, Epilepsy: Frequency, Causes and Consequences, Demos, New York, 1990.
29. Jones K.H., Senft J.A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33:1985;77-79.
30. Kamphuis W., Gorter J.A., Wadman W.J., Lopes da Silva F.H. Hippocampal kindling leads to different changes in paired-pulse depression of local evoked field potentials in CA1 area and in fascia dentata. Neurosci. Lett. 141:1992;101-105.
31. Kapur J., Lothman E.W. Loss of inhibition precedes delayed spontaneous seizures in the hippocampus after tetanic electrical stimulation. J. Neurophysiol. 61:1989;427-434.
32. A receptors during partial status epilepticus. Neurology. 44:1994;2407-2408.
33. A receptors. J. Neurosci. 17:1997;7532-7540.
34. Kocsis J.D., Rand M.N., Lankford K.L., Waxman S.G. Intracellular calcium mobilization and neurite outgrowth in mammalian neurons. J. Neurobiol. 25:1994;252-264.
35. Liu J., Farmer J.D.J., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
36. Lothman E.W., Bertram E.H., Stringer J.L. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 37:1991;1-82.
37. Lynch G., Larson J., Kelso S., Barrionuevo G., Schottler F. Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature. 305:1983;719-721.
38. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 36(2):1995;S2-S12. Suppl.
39. Malenka R.C., Kauer J.A., Zucker R.S., Nicoll R.A. Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science. 242:1988;81-84.
40. McGlade-McCulloh E., Yamamoto H., Tan S.E., Brickey D.A., Soderling T.R. Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature. 362:1993;640-642.
41. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia. 37(6):1996;S4-S11. Suppl.
42. Melloni E., Pontremoli S. The calpains. Trends Neurosci. 12:1989;438-444.
43. 2+/calmodulin-dependent kinase. Mol. Cell Biol. 15:1995;3672-3684.
44. Nichols R.A., Suplick G.R., Brown J.M. Calcineurin-mediated protein dephosphorylation in brain nerve terminals regulates the release of glutamate. J. Biol. Chem. 269:1994;23817-23823.
45. Perlin J.B., Churn S.B., Lothman E.W., DeLorenzo R.J. Loss of type II calcium/calmodulin-dependent kinase activity correlates with stages of development of electrographic seizures in status epilepticus in rat. Epilepsy Res. 11:1992;111-118.
46. J.B. Perlin, R.J. DeLorenzo, Epilepsy, in: T.A. Pedley, B.S. Meldrum (Eds.), Recent Advances in Epilepsy, Churchill Livingston, New York, 1992.
47. 2+/calmodulin-dependent protein kinase II. Biophys. J. 50:1986;319-327.
48. Shibasaki F., McKeon F. Calcineurin functions in Ca(2+)-activated cell death in mammalian cells. J. Cell Biol. 131:1995;735-743.
49. Shields S.M., Ingebritsen T.S., Kelly P.T. Identification of protein phosphatase 1 in synaptic junctions: dephosphorylation of endogenous calmodulin-dependent kinase II and synapse-enriched phosphoproteins. J. Neurosci. 5:1985;3414-3422.
50. Soderling T.R. Calcium/calmodulin-dependent protein kinase II: role in learning and memory. Mol. Cell Biochem. 127-128:1993;93-101.
51. Sombati S., Coulter D.A., DeLorenzo R.J. Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res. 566:1991;316-319.
52. Sombati S., DeLorenzo R.J. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73:1995;1706-1711.
53. Wang R.A., Cheng G., Kolaj M., Randic M. Alpha-subunit of calcium/calmodulin-dependent protein kinase II enhances gamma-aminobutyric acid and inhibitory synaptic responses of rat neurons in vitro. J. Neurophysiol. 73:1995;2099-2106.
54. Wasterlain C.G., Farber D.B. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 81:1984;1253-1257.
55. Yakel J.L. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol. Sci. 18:1997;124-134.